Past, Current, and Future Cancer Clinical Research Collaborations: The Case of the European Organisation for Research and Treatment of Cancer
Although collaborations between academic institutions and industry have led to important scientific breakthroughs in the discovery stage of the pharmaceutical research and development process, the role of multistakeholder partnerships in the clinical development of anticancer medicines necessitates...
Main Authors: | Stefanie Broes, Robbe Saesen, Denis Lacombe, Isabelle Huys |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2021-01-01
|
Series: | Clinical and Translational Science |
Online Access: | https://doi.org/10.1111/cts.12863 |
Similar Items
-
Views of European Drug Development Stakeholders on Treatment Optimization and Its Potential for Use in Decision-Making
by: Robbe Saesen, et al.
Published: (2020-02-01) -
Sharing of Clinical Trial Data and Samples: The Cancer Patient Perspective
by: Stefanie Broes, et al.
Published: (2020-02-01) -
Toward a Tiered Model to Share Clinical Trial Data and Samples in Precision Oncology
by: Stefanie Broes, et al.
Published: (2018-01-01) -
Integration of Translational Research in the European Organization for Research and Treatment of Cancer Research (EORTC) Clinical Trial Cooperative Group Mechanisms
by: Eggermont Alexander MM, et al.
Published: (2003-08-01) -
Past, Current, and Future of Immunotherapies for Prostate Cancer
by: Adeline N. Boettcher, et al.
Published: (2019-09-01)